Pathways mediating Ca2+ entry in rat cerebellar granule cells following in vitro exposure to methyl mercury

Toxicology and Applied Pharmacology

Volumn 147, Issue 2, 1997, Pages 319-330

  Sue Marty, M ^a   Atchison, William D ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; ENVIRONMENTAL CHEMICAL; METHYLMERCURY; NIFEDIPINE; OMEGA CONOTOXIN; SODIUM CHANNEL; TETRODOTOXIN; AMINO ACID RECEPTOR BLOCKING AGENT; CALCIUM; METHYLMERCURIC CHLORIDE; METHYLMERCURY DERIVATIVE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CEREBELLUM; CONTROLLED STUDY; FLUORESCENCE; GRANULE CELL; NONHUMAN; RAT; ANIMAL; CELL CULTURE; CELL MEMBRANE; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELL MEMBRANE; CELLS, CULTURED; CEREBELLUM; EXCITATORY AMINO ACID ANTAGONISTS; METHYLMERCURY COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; TETRODOTOXIN;

EID: 0031309785     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8262     Document Type: Article

References (73)

1. Amico C., Marchetti C., Nobile M., Usai C. Pharmacological types of calcium channels and their modulation by baclofen in cerebellar granule cells. J. Neurosci. 15:1995;2839-2848.
2. Aronica E., Condorelli D. F., Nicoletti F., Dell'Albani P., Amico C., Balazs R. Metabotropic glutamate receptors in cultured cerebellar granule cells: developmental profile. J. Neurochem. 60:1993;559-565.
3. 2+2+. J. Biol. Chem. 260:1985;2719-2727.
4. Aschner M., Eberle N. B., Miller K., Kimelberg H. K. Interactions of methylmercury with rat primary astrocyte cultures: inhibition of rubidium and glutamate uptake and induction of swelling. Brain Res. 530:1990;245-250.
5. Aschner M., Du Y.-L., Gannon M., Kimelberg H. K. Methylmercury-induced alterations in excitatory amino acid transport in rat primary astrocyte cultures. Brain Res. 602:1993;181-186.
6. Atchison W. D. Extracellular calcium-dependent and -independent effects of methylmercury on spontaneous and potassium-evoked release of acetylcholine at the neuromuscular junction. J. Pharmacol. Exp. Ther. 237:1986;672-680.
7. Atchison W. D., Narahashi T. Methylmercury-induced depression of neuromuscular transmission in the rat. NeuroToxicology. 3:1982;37-50.
8. Atchison W. D., Joshi U., Thornburg J. E. Irreversible suppression of calcium entry into nerve terminals by methylmercury. J. Pharmacol. Exp. Ther. 238:1986;618-624.
9. Atchison W. D., Adgate L., Beaman C. M. Effects of antibiotics on uptake of calcium into isolated nerve terminals. J. Pharmacol. Exp. Ther. 245:1988;394-401.
10. Bakir F., Damluji S. F., Amin-Zaki L., Murtadha M., Khalidi A., El-Rawi N. Y., Tikriti S., Daharir H. I., Clarkson T. W., Smith J. C., Doherty R. A. Methylmercury poisoning in Iraq. Science. 181:1973;230-241.
11. Bondy S. C., Anderson C. L., Harrington M. E., Prasad K. N. The effects of organic and inorganic lead and mercury on neurotransmitter high-affinity transport and release mechanisms. Environ. Res. 19:1979;102-111.
12. 2+. Trends Pharmacol. Sci. 13:1992;256-262.
13. Choi D. W. Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci. Lett. 58:1985;293-297.
14. Choi D. W. Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage. Trends Neurosci. 10:1988;465-469.
15. Conn P. M. Methods in Neurosciences Vol. 2. Cell Culture. 1990;Academic Press, New York.
16. Courtney M. J., Lambert J. J., Nicholls D. G. The interactions between plasma membrane depolarization and glutamate receptor activation in the regulation of cytoplasmic free calcium in cultured cerebellar granule cells. J. Neurosci. 10:1990;3873-3879.
17. Coyle J. T. Neurotoxic action of kainic acid. J. Neurochem. 41:1983;1-11.
18. Davies S. N., Martin D., Millar J. D., Aram J. A., Church J., Lodge D. Differences in results fromin vivoin vitroN. Eur. J. Pharmacol. 145:1988;141-151.
19. 19. J. Neurochem. 63:1994;383-386.
20. Denny M. F., Hare M. F., Atchison W. D. Methylmercury alters intrasynaptosomal concentrations of endogenous polyvalent cations. Toxicol. Appl. Pharmacol. 122:1993;222-232.
21. Dubinsky J. M. Examination of the role of calcium in neuronal death. Ann. N.Y. Acad. Sci. 679:1993;34-42.
22. Farley J. M., Wu C. H., Narahashi T. Mechanism of neuromuscular block by streptomycin: A voltage clamp analysis. J. Pharmacol. Exp. Ther. 222:1982;488-493.
23. Felder C. C., Singer-Lahat D., Mathes C. Voltage-independent calcium channels: Regulation by receptors and intracellular calcium stores. Biochem. Pharmacol. 48:1994;1997-2004.
24. Foster A. C., Wong E. H. The novel anticonvulsant MK-801 binds to the activated state of theND. Br. J. Pharmacol. 91:1987;403-409.
25. Fox A. P., Nowycky M. C., Tsien R. W. Kinetic and pharmacological properties distinguish three types of calcium current in chick sensory neurones. J. Physiol. (London). 394:1987;149-172.
26. 2+. J. Biol. Chem. 260:1985;3440-3450.
27. Hare M. F., Atchison W. D. Comparative actions of methylmercury and divalent inorganic mercury on nerve terminal and intraterminal mitochondrial membrane potentials. J. Pharmacol. Exp. Ther. 261:1992;166-172.
28. ++. J. Pharmacol. Exp. Ther. 272:1995a;1016-1023.
29. i. Toxicol. Appl. Pharmacol. 135:1995b;299-307.
30. ++. J. Pharmacol. Exp. Ther. 266:1993;1626-1635.
31. 2+. J. Neurosci. 13:1993;1148-1156.
32. 452+. Toxicol. Appl. Pharmacol. 113:1992;267-273.
33. Hille B. Ionic channels in nerve membranes. Prog. Biophys. Mol. Biol. 21:1970;1-32.
34. Honore T., Davies S. N., Drejer J., Fletcher E. J., Jacobsen P., Lodge D., Nielsen F. E. Quinoxalinediones: Potent competitive non-NMDA glutamate receptor antagonists. Science. 241:1988;701-703.
35. Hughes W. L. A physiochemical rationale for the biological activity of mercury and its compounds. Ann. N.Y. Acad. Sci. 65:1957;454-460.
36. Hunter D., Russell D. S. Focal cerebral and cerebellar atrophy in a human subject due to organic mercury compounds. Neurol. Neurosurg. Psychiat. 17:1954;235-241.
37. Juang M. S. Depression of frog muscle contraction by methylmercuric chloride and mercuric chloride. Toxicol. Appl. Pharmacol. 35:1976;183-185.
38. Kauppinen R. A., Komulainen H., Taipale H. Cellular mechanisms underlying the increase in cytosolic free calcium concentration induced by methylmercury in cerebrocortical synaptosomes from guinea pig. J. Pharmacol. Exp. Ther. 248:1989;1248-1254.
39. 2+. Toxicol. Appl. Pharmacol. 88:1987;77-86.
40. Komulainen H., Tuomisto J. Interference of methyl mercury with monoamine uptake and release in rat brain synaptosomes. Acta Pharmacol. Toxicol. 48:1981;214-222.
41. Leonhart R., Haas H., Büsselberg D. Methyl mercury reduces voltage-activated currents of rat dorsal root ganglion neurons. Naunyn Schmiedebergs Arch. Pharmacol. 354:1996;532-538.
42. Leyshon-Sorland K., Jasani B., Morgan A. J. The localization of mercury and metallothionein in the cerebellum of rats experimentally exposed to methylmercury. Histochem. J. 26:1994;161-169.
43. Lysko P. G., Lysko K. A., Webb C. L., Feuerstein G. Neuroprotective effects of carvedilol, a new antihypertensive, at theND. Neurosci. Lett. 148:1992;34-38.
44. Mayer M. L., Westbrook G. L. Cellular mechanisms underlying excitotoxicity. Trends Neurosci. 10:1987;59-61.
45. 2+. Nature (London). 309:1984;261-263.
46. Mendelowitz D., Bacal K., Kunze D. L. Bradykinin-activated calcium influx pathway in bovine aortic endothelial cells. Am. J. Physiol. 262:1992;H942-948.
47. Minnema D. J., Cooper G. P., Greenland R. D. Effects of methyl mercury on neurotransmitter release from rat brain synaptosomes. Toxicol. Appl. Pharmacol. 99:1989;510-521.
48. Moore J. W., Blaustein M. P., Anderson N. C., Narahashi T. Basis of tetrodotoxin's selectivity in blockage of squid axons. J. Gen. Physiol. 50:1967;1401-1411.
49. Muller D., Joly M., Lynch G. Contributions of quisqualate and NMDA receptors to the induction and expression of LTP. Science. 242:1988;1694-1697.
50. Nachhsen D. A. Selectivity of the Ca binding site in synaptosome Ca channels: Inhibition of Ca influx by multivalent metal cations. J. Gen. Physiol. 83:1984;941-967.
51. Nicoletti F., Wroblewski J. T., Novelli A., Alho H., Guidotti A., Costa E. The activation of inositol phospholipid metabolism as a signal transducting system for excitatory amino acids in primary cultures of cerebellar granule cells. J. Neurosci. 6:1986;1905-1911.
52. Nowak L., Bregestovski P., Ascher P., Herbet A., Prochiantz A. Magnesium gates glutamate-activated channels in mouse central neurones. Nature (London). 307:1984;462-465.
53. 2+. J. Physiol. (London). 482.3:1995;493-509.
54. Peterson B. Z., Catterall W. A. Calcium binding in the pore of L-type calcium channels modulates high affinity dihydropyridine binding. J. Biol. Chem. 270:1995;18201-18204.
55. Rabenstein D. L. The chemistry of methylmercury toxicology. J. Chem. Educ. 55:1978;292-296.
56. Raff M. C., Fields K. L., Hakomori S.-I., Mirsky R., Pruss R. M., Winter J. Cell-type-specific markers for distinguishing and studying neurons and the major classes of glial cells in culture. Brain Res. 174:1979;283-308.
57. 2+. J. Neurosci. 15:1995;2995-3012.
58. Redman R. S., Silinsky E. M. Decrease in calcium currents induced by aminoglycoside antibiotics in frog motor nerve endings. Br. J. Pharmacol. 113:1994;375-378.
59. Regehr W. G., Atluri P. P. Calcium transients in cerebellar granule cell presynaptic terminals. Biophys. J. 68:1995;2156-2170.
60. Rossi P., D'Angelo E., Magistretti J., Toselli M., Taglietti V. Age-dependent expression of high-voltage activated calcium currents during cerebellar granule cell developmentin situ. Pflügers Arch. Eur. J. Physiol. 429:1994;107-116.
61. Rothstein A. Mercaptans, the biological targets for mercurials. Mercurials and Mercaptans. 1973;Thomas, Springfield. p. 68-70.
62. 2+. J. Neurochem. 61:1993;648-657.
63. Schramm M., Eimerl S., Costa E. Serum and depolarizing agents cause acute neurotoxicity in cultured cerebellar granule cells: role of glutamate receptor responsive toND. Proc. Natl. Acad. Sci. USA. 87:1990;1193-1197.
64. 2+. Proc. Natl. Acad. Sci. USA. 91:1994;878-882.
65. 45+++. J. Pharmacol. Exp. Ther. 248:1989;696-702.
66. ++. J. Pharmacol. Exp. Ther. 258:1991;149-157.
67. 2+. Mol. Pharmacol. 38:1990;102-113.
68. Sirois J. E., Atchison W. D. Effect of ω-conotoxin GVIA and nimodipine on methylmercury (MeHg)-induced block of whole cell barium current in cerebellar granule neurons. Toxicologist. 36:1997;61.
69. Sladeczek F., Pin J. P., Recasens M., Bockaert J., Weiss S. Glutamate stimulates inositol phosphate formation in striatal neurons. Nature (London). 317:1985;717-718.
70. Steel R. G. D., Torrie J. H. Principles and Procedures of Statistics. 1960;McGraw-Hill, New York.
71. Weiss J. H., Hartley D. M., Koh J., Choi D. W. The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity. Science. 247:1990;1474-1477.
72. 2+. Science. 264:1994;107-111.
73. Winegar B. D., Kelly R., Lansman J. B. Block of current through single calcium channels by Fe, Co, and Ni. J. Gen. Physiol. 97:1991;351-367.